The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dermatology OTC Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Dermatology OTC Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dermatology OTC Medications market size is estimated to be worth US$ 13150 million in 2021 and is forecast to a readjusted size of USD 16350 million by 2028 with a CAGR of 3.2% during review period. Hospital accounting for % of the Dermatology OTC Medications global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While External Use segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dermatology OTC Medications include Bayer, GSK, Teva, Johnson & Johnson, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dermatology OTC Medications market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
External Use
Oral
Market segment by Application can be divided into
Hospital
Drug Store
Other
The key market players for global Dermatology OTC Medications market are listed below:
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology OTC Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology OTC Medications, with price, sales, revenue and global market share of Dermatology OTC Medications from 2019 to 2022.
Chapter 3, the Dermatology OTC Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology OTC Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dermatology OTC Medications market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dermatology OTC Medications.
Chapter 13, 14, and 15, to describe Dermatology OTC Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Dermatology OTC Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dermatology OTC Medications market size is estimated to be worth US$ 13150 million in 2021 and is forecast to a readjusted size of USD 16350 million by 2028 with a CAGR of 3.2% during review period. Hospital accounting for % of the Dermatology OTC Medications global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While External Use segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dermatology OTC Medications include Bayer, GSK, Teva, Johnson & Johnson, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dermatology OTC Medications market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
External Use
Oral
Market segment by Application can be divided into
Hospital
Drug Store
Other
The key market players for global Dermatology OTC Medications market are listed below:
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology OTC Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology OTC Medications, with price, sales, revenue and global market share of Dermatology OTC Medications from 2019 to 2022.
Chapter 3, the Dermatology OTC Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology OTC Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dermatology OTC Medications market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dermatology OTC Medications.
Chapter 13, 14, and 15, to describe Dermatology OTC Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Dermatology OTC Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatology OTC Medications Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 External Use
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatology OTC Medications Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Global Dermatology OTC Medications Market Size & Forecast
1.4.1 Global Dermatology OTC Medications Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dermatology OTC Medications Sales in Volume (2017-2028)
1.4.3 Global Dermatology OTC Medications Price (2017-2028)
1.5 Global Dermatology OTC Medications Production Capacity Analysis
1.5.1 Global Dermatology OTC Medications Total Production Capacity (2017-2028)
1.5.2 Global Dermatology OTC Medications Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatology OTC Medications Market Drivers
1.6.2 Dermatology OTC Medications Market Restraints
1.6.3 Dermatology OTC Medications Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Dermatology OTC Medications Product and Services
2.1.4 Bayer Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Dermatology OTC Medications Product and Services
2.2.4 GSK Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Dermatology OTC Medications Product and Services
2.3.4 Teva Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Dermatology OTC Medications Product and Services
2.4.4 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Dermatology OTC Medications Product and Services
2.5.4 Novartis Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Dermatology OTC Medications Product and Services
2.6.4 Mylan Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Dermatology OTC Medications Product and Services
2.7.4 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Aurobindo
2.8.1 Aurobindo Details
2.8.2 Aurobindo Major Business
2.8.3 Aurobindo Dermatology OTC Medications Product and Services
2.8.4 Aurobindo Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Galderma
2.9.1 Galderma Details
2.9.2 Galderma Major Business
2.9.3 Galderma Dermatology OTC Medications Product and Services
2.9.4 Galderma Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CR SANJIU
2.10.1 CR SANJIU Details
2.10.2 CR SANJIU Major Business
2.10.3 CR SANJIU Dermatology OTC Medications Product and Services
2.10.4 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Dr. Reddy's
2.11.1 Dr. Reddy's Details
2.11.2 Dr. Reddy's Major Business
2.11.3 Dr. Reddy's Dermatology OTC Medications Product and Services
2.11.4 Dr. Reddy's Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Lupin
2.12.1 Lupin Details
2.12.2 Lupin Major Business
2.12.3 Lupin Dermatology OTC Medications Product and Services
2.12.4 Lupin Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Bausch Health
2.13.1 Bausch Health Details
2.13.2 Bausch Health Major Business
2.13.3 Bausch Health Dermatology OTC Medications Product and Services
2.13.4 Bausch Health Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Cipla
2.14.1 Cipla Details
2.14.2 Cipla Major Business
2.14.3 Cipla Dermatology OTC Medications Product and Services
2.14.4 Cipla Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Qilu Pharmaceutical
2.15.1 Qilu Pharmaceutical Details
2.15.2 Qilu Pharmaceutical Major Business
2.15.3 Qilu Pharmaceutical Dermatology OTC Medications Product and Services
2.15.4 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Almirall
2.16.1 Almirall Details
2.16.2 Almirall Major Business
2.16.3 Almirall Dermatology OTC Medications Product and Services
2.16.4 Almirall Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Lingrui
2.17.1 Lingrui Details
2.17.2 Lingrui Major Business
2.17.3 Lingrui Dermatology OTC Medications Product and Services
2.17.4 Lingrui Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dermatology OTC Medications Breakdown Data by Manufacturer
3.1 Global Dermatology OTC Medications Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dermatology OTC Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dermatology OTC Medications
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatology OTC Medications Manufacturer Market Share in 2021
3.4.2 Top 6 Dermatology OTC Medications Manufacturer Market Share in 2021
3.5 Global Dermatology OTC Medications Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dermatology OTC Medications Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dermatology OTC Medications Market Size by Region
4.1.1 Global Dermatology OTC Medications Sales in Volume by Region (2017-2028)
4.1.2 Global Dermatology OTC Medications Revenue by Region (2017-2028)
4.2 North America Dermatology OTC Medications Revenue (2017-2028)
4.3 Europe Dermatology OTC Medications Revenue (2017-2028)
4.4 Asia-Pacific Dermatology OTC Medications Revenue (2017-2028)
4.5 South America Dermatology OTC Medications Revenue (2017-2028)
4.6 Middle East and Africa Dermatology OTC Medications Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dermatology OTC Medications Sales in Volume by Type (2017-2028)
5.2 Global Dermatology OTC Medications Revenue by Type (2017-2028)
5.3 Global Dermatology OTC Medications Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dermatology OTC Medications Sales in Volume by Application (2017-2028)
6.2 Global Dermatology OTC Medications Revenue by Application (2017-2028)
6.3 Global Dermatology OTC Medications Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dermatology OTC Medications Sales by Type (2017-2028)
7.2 North America Dermatology OTC Medications Sales by Application (2017-2028)
7.3 North America Dermatology OTC Medications Market Size by Country
7.3.1 North America Dermatology OTC Medications Sales in Volume by Country (2017-2028)
7.3.2 North America Dermatology OTC Medications Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dermatology OTC Medications Sales by Type (2017-2028)
8.2 Europe Dermatology OTC Medications Sales by Application (2017-2028)
8.3 Europe Dermatology OTC Medications Market Size by Country
8.3.1 Europe Dermatology OTC Medications Sales in Volume by Country (2017-2028)
8.3.2 Europe Dermatology OTC Medications Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dermatology OTC Medications Sales by Type (2017-2028)
9.2 Asia-Pacific Dermatology OTC Medications Sales by Application (2017-2028)
9.3 Asia-Pacific Dermatology OTC Medications Market Size by Region
9.3.1 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dermatology OTC Medications Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dermatology OTC Medications Sales by Type (2017-2028)
10.2 South America Dermatology OTC Medications Sales by Application (2017-2028)
10.3 South America Dermatology OTC Medications Market Size by Country
10.3.1 South America Dermatology OTC Medications Sales in Volume by Country (2017-2028)
10.3.2 South America Dermatology OTC Medications Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dermatology OTC Medications Sales by Type (2017-2028)
11.2 Middle East & Africa Dermatology OTC Medications Sales by Application (2017-2028)
11.3 Middle East & Africa Dermatology OTC Medications Market Size by Country
11.3.1 Middle East & Africa Dermatology OTC Medications Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dermatology OTC Medications Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dermatology OTC Medications and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dermatology OTC Medications
12.3 Dermatology OTC Medications Production Process
12.4 Dermatology OTC Medications Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dermatology OTC Medications Typical Distributors
13.3 Dermatology OTC Medications Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Dermatology OTC Medications Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dermatology OTC Medications Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Dermatology OTC Medications Product and Services
Table 6. Bayer Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Dermatology OTC Medications Product and Services
Table 10. GSK Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Dermatology OTC Medications Product and Services
Table 14. Teva Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Dermatology OTC Medications Product and Services
Table 18. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Dermatology OTC Medications Product and Services
Table 22. Novartis Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Dermatology OTC Medications Product and Services
Table 26. Mylan Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharmaceutical Major Business
Table 29. Sun Pharmaceutical Dermatology OTC Medications Product and Services
Table 30. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 32. Aurobindo Major Business
Table 33. Aurobindo Dermatology OTC Medications Product and Services
Table 34. Aurobindo Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Galderma Basic Information, Manufacturing Base and Competitors
Table 36. Galderma Major Business
Table 37. Galderma Dermatology OTC Medications Product and Services
Table 38. Galderma Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CR SANJIU Basic Information, Manufacturing Base and Competitors
Table 40. CR SANJIU Major Business
Table 41. CR SANJIU Dermatology OTC Medications Product and Services
Table 42. CR SANJIU Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 44. Dr. Reddy's Major Business
Table 45. Dr. Reddy's Dermatology OTC Medications Product and Services
Table 46. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Lupin Basic Information, Manufacturing Base and Competitors
Table 48. Lupin Major Business
Table 49. Lupin Dermatology OTC Medications Product and Services
Table 50. Lupin Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 52. Bausch Health Major Business
Table 53. Bausch Health Dermatology OTC Medications Product and Services
Table 54. Bausch Health Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Cipla Basic Information, Manufacturing Base and Competitors
Table 56. Cipla Major Business
Table 57. Cipla Dermatology OTC Medications Product and Services
Table 58. Cipla Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Qilu Pharmaceutical Major Business
Table 61. Qilu Pharmaceutical Dermatology OTC Medications Product and Services
Table 62. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Almirall Basic Information, Manufacturing Base and Competitors
Table 64. Almirall Major Business
Table 65. Almirall Dermatology OTC Medications Product and Services
Table 66. Almirall Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Lingrui Basic Information, Manufacturing Base and Competitors
Table 68. Lingrui Major Business
Table 69. Lingrui Dermatology OTC Medications Product and Services
Table 70. Lingrui Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Dermatology OTC Medications Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Units)
Table 72. Global Dermatology OTC Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Dermatology OTC Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Dermatology OTC Medications Production Capacity by Company, (M Units): 2020 VS 2021
Table 75. Head Office and Dermatology OTC Medications Production Site of Key Manufacturer
Table 76. Dermatology OTC Medications New Entrant and Capacity Expansion Plans
Table 77. Dermatology OTC Medications Mergers & Acquisitions in the Past Five Years
Table 78. Global Dermatology OTC Medications Sales by Region (2017-2022) & (M Units)
Table 79. Global Dermatology OTC Medications Sales by Region (2023-2028) & (M Units)
Table 80. Global Dermatology OTC Medications Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Dermatology OTC Medications Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 83. Global Dermatology OTC Medications Sales by Type (2023-2028) & (M Units)
Table 84. Global Dermatology OTC Medications Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Dermatology OTC Medications Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Dermatology OTC Medications Price by Type (2017-2022) & (USD/Unit)
Table 87. Global Dermatology OTC Medications Price by Type (2023-2028) & (USD/Unit)
Table 88. Global Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 89. Global Dermatology OTC Medications Sales by Application (2023-2028) & (M Units)
Table 90. Global Dermatology OTC Medications Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Dermatology OTC Medications Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Dermatology OTC Medications Price by Application (2017-2022) & (USD/Unit)
Table 93. Global Dermatology OTC Medications Price by Application (2023-2028) & (USD/Unit)
Table 94. North America Dermatology OTC Medications Sales by Country (2017-2022) & (M Units)
Table 95. North America Dermatology OTC Medications Sales by Country (2023-2028) & (M Units)
Table 96. North America Dermatology OTC Medications Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Dermatology OTC Medications Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 99. North America Dermatology OTC Medications Sales by Type (2023-2028) & (M Units)
Table 100. North America Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 101. North America Dermatology OTC Medications Sales by Application (2023-2028) & (M Units)
Table 102. Europe Dermatology OTC Medications Sales by Country (2017-2022) & (M Units)
Table 103. Europe Dermatology OTC Medications Sales by Country (2023-2028) & (M Units)
Table 104. Europe Dermatology OTC Medications Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Dermatology OTC Medications Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 107. Europe Dermatology OTC Medications Sales by Type (2023-2028) & (M Units)
Table 108. Europe Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 109. Europe Dermatology OTC Medications Sales by Application (2023-2028) & (M Units)
Table 110. Asia-Pacific Dermatology OTC Medications Sales by Region (2017-2022) & (M Units)
Table 111. Asia-Pacific Dermatology OTC Medications Sales by Region (2023-2028) & (M Units)
Table 112. Asia-Pacific Dermatology OTC Medications Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Dermatology OTC Medications Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 115. Asia-Pacific Dermatology OTC Medications Sales by Type (2023-2028) & (M Units)
Table 116. Asia-Pacific Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 117. Asia-Pacific Dermatology OTC Medications Sales by Application (2023-2028) & (M Units)
Table 118. South America Dermatology OTC Medications Sales by Country (2017-2022) & (M Units)
Table 119. South America Dermatology OTC Medications Sales by Country (2023-2028) & (M Units)
Table 120. South America Dermatology OTC Medications Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Dermatology OTC Medications Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 123. South America Dermatology OTC Medications Sales by Type (2023-2028) & (M Units)
Table 124. South America Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 125. South America Dermatology OTC Medications Sales by Application (2023-2028) & (M Units)
Table 126. Middle East & Africa Dermatology OTC Medications Sales by Region (2017-2022) & (M Units)
Table 127. Middle East & Africa Dermatology OTC Medications Sales by Region (2023-2028) & (M Units)
Table 128. Middle East & Africa Dermatology OTC Medications Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Dermatology OTC Medications Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 131. Middle East & Africa Dermatology OTC Medications Sales by Type (2023-2028) & (M Units)
Table 132. Middle East & Africa Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 133. Middle East & Africa Dermatology OTC Medications Sales by Application (2023-2028) & (M Units)
Table 134. Dermatology OTC Medications Raw Material
Table 135. Key Manufacturers of Dermatology OTC Medications Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Dermatology OTC Medications Typical Distributors
Table 139. Dermatology OTC Medications Typical Customers
List of Figures
Figure 1. Dermatology OTC Medications Picture
Figure 2. Global Dermatology OTC Medications Revenue Market Share by Type in 2021
Figure 3. External Use
Figure 4. Oral
Figure 5. Global Dermatology OTC Medications Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Other
Figure 9. Global Dermatology OTC Medications Revenue, (USD Million) & (M Units): 2017 & 2021 & 2028
Figure 10. Global Dermatology OTC Medications Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Dermatology OTC Medications Sales (2017-2028) & (M Units)
Figure 12. Global Dermatology OTC Medications Price (2017-2028) & (USD/Unit)
Figure 13. Global Dermatology OTC Medications Production Capacity (2017-2028) & (M Units)
Figure 14. Global Dermatology OTC Medications Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Dermatology OTC Medications Market Drivers
Figure 16. Dermatology OTC Medications Market Restraints
Figure 17. Dermatology OTC Medications Market Trends
Figure 18. Global Dermatology OTC Medications Sales Market Share by Manufacturer in 2021
Figure 19. Global Dermatology OTC Medications Revenue Market Share by Manufacturer in 2021
Figure 20. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Dermatology OTC Medications Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Dermatology OTC Medications Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Dermatology OTC Medications Sales Market Share by Region (2017-2028)
Figure 24. Global Dermatology OTC Medications Revenue Market Share by Region (2017-2028)
Figure 25. North America Dermatology OTC Medications Revenue (2017-2028) & (USD Million)
Figure 26. Europe Dermatology OTC Medications Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Dermatology OTC Medications Revenue (2017-2028) & (USD Million)
Figure 28. South America Dermatology OTC Medications Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Dermatology OTC Medications Revenue (2017-2028) & (USD Million)
Figure 30. Global Dermatology OTC Medications Sales Market Share by Type (2017-2028)
Figure 31. Global Dermatology OTC Medications Revenue Market Share by Type (2017-2028)
Figure 32. Global Dermatology OTC Medications Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Dermatology OTC Medications Sales Market Share by Application (2017-2028)
Figure 34. Global Dermatology OTC Medications Revenue Market Share by Application (2017-2028)
Figure 35. Global Dermatology OTC Medications Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Dermatology OTC Medications Sales Market Share by Type (2017-2028)
Figure 37. North America Dermatology OTC Medications Sales Market Share by Application (2017-2028)
Figure 38. North America Dermatology OTC Medications Sales Market Share by Country (2017-2028)
Figure 39. North America Dermatology OTC Medications Revenue Market Share by Country (2017-2028)
Figure 40. United States Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Dermatology OTC Medications Sales Market Share by Type (2017-2028)
Figure 44. Europe Dermatology OTC Medications Sales Market Share by Application (2017-2028)
Figure 45. Europe Dermatology OTC Medications Sales Market Share by Country (2017-2028)
Figure 46. Europe Dermatology OTC Medications Revenue Market Share by Country (2017-2028)
Figure 47. Germany Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Dermatology OTC Medications Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Dermatology OTC Medications Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Dermatology OTC Medications Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Dermatology OTC Medications Revenue Market Share by Region (2017-2028)
Figure 56. China Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Dermatology OTC Medications Sales Market Share by Type (2017-2028)
Figure 63. South America Dermatology OTC Medications Sales Market Share by Application (2017-2028)
Figure 64. South America Dermatology OTC Medications Sales Market Share by Country (2017-2028)
Figure 65. South America Dermatology OTC Medications Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Dermatology OTC Medications Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Dermatology OTC Medications Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Dermatology OTC Medications Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Dermatology OTC Medications Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Dermatology OTC Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Dermatology OTC Medications in 2021
Figure 77. Manufacturing Process Analysis of Dermatology OTC Medications
Figure 78. Dermatology OTC Medications Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
